5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethylpropyl]-2-yodo-1H-Indole CAS 2641451-43-4

Deskripsyon Product:

Non pwodwi:

5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethylpropyl]-2-yodo-1H-Indole CAS 2641451-43-4

 

 

Sinonim:

[3-(5-bromo-2-yodo-1H-indol-3-yl)-2,2-dimethylpropoxy]-tèt-butil-diphenylsilane

1H-indol, 5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilil]oxy]-2,2-dimethylpropyl]-2-yodo-

 

 

Pwopriyete Chimik ak Fizik

Aparans: Off-blan rive jòn Solid

Esè: NLT97%

Pwen bouyi: 621.1 degre (lit.)

Dansite: 1.45 g / cm3

pKa:14.87

 

 

Aplikasyon: Entèmedyè nan Daraxonrasib;

Konpoze sa a sèvi kòm yon précurseur enpòtan nan sentèz ti -dwòg konplèks ki vize tankou inibitè RAS. Nan wout sentèz dwòg ki gen rapò, li se souvan itilize kòm yon materyèl depa oswa entèmedyè kle pou konstwi kad konplèks macrocyclic oswa fusion -bag, k ap patisipe nan reyaksyon sikilasyon entramolekilè ki vin apre yo pwodwi konpoze heterocyclic polisiklik ak aktivite farmakolojik espesifik.

 

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: 5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilil]oxy]-2,2-dimethylpropyl]-2-iodo-1h-indole cas 2641451-43-4, manifaktirè, founisè, faktori, achte, nan stock

• On: Methyl(S)-1-((S)-3-(4-bromothiazol-2-yl)-2-((tèt-butoxicarbonyl)amino)propanoyl)hexahydropyridazin-3-carboxylate CAS 2641451-75-2
• Pwochen: Bromo-3-(3-((tèt-butyldiphenylsilyl)oxy)-2,2-dimethylpropyl)-1H-indol CAS 2641451-59-2